Metformin for asthma in overweight adults
Part of Hormones & metabolism, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests whether the diabetes drug metformin can help people with asthma who are also overweight or obese. The goal is to see if it improves asthma control and reduces the need for rescue medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have asthma that is not well controlled, even with your regular medications.
- You are overweight or obese (BMI of 25 or higher).
- You are 18 years old or older.
- You are not pregnant, planning to become pregnant, or breastfeeding.
- You do not have serious heart, kidney, liver, or lung disease, or diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how weight and blood-sugar/fat changes in the body may affect the airways in people with asthma. You may be asked to complete breathing tests and possibly an airway procedure (bronchoscopy) to help researchers compare groups.
This study tests whether a diabetes medication called metformin can help children ages 10–17 who are overweight or obese and have asthma that isn't well controlled. Researchers hope it may improve their asthma symptoms and breathing.
This trial tests whether metformin, a common diabetes medicine, can help people with obesity lose weight. It is for people who do not have diabetes and have not used weight loss treatments in the past year.
This trial tests whether adding metformin (a diabetes medicine) to usual antidepressant treatment can help improve depression in people who are overweight or obese. It is for adults age 18–44 who are newly diagnosed with depression and do not have diabetes.
This trial tests whether metformin can help adults with intellectual disability who gained weight from long-term antipsychotic medicines. If you qualify, you may be assigned metformin to improve weight and related health measures.
This trial tests a long-acting metformin pill in people with both type 2 diabetes and coronary heart disease. It aims to see if metformin can safely help control blood sugar in this specific group.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.